The incidence of early-onset oral cavity squamous cell carcinoma on the tongue, the most common subsite, increased over time.
Skin malignancies are the most common cancers in the United States. 1 Typically, skin cancer is categorized as either melanoma or nonmelanoma skin cancer, which is also known as keratinocyte ...
UNLOXCYT is an evolution in checkpoint inhibition and is now available for the treatment of adults in the U.S. with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC ...
For patients with locally advanced esophageal cancer, front-loading immunotherapy with induction chemo and chemoradiotherapy, ...
Variations in the use of definitive chemoradiotherapy and immunoradiotherapy for patients with locally advanced head and neck cancer. This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting ...
Anti–PD-1 therapy (pembrolizumab, nivolumab) supports neoadjuvant and adjuvant management of higher-risk melanoma, offering durable remissions with less systemic toxicity than traditional chemotherapy ...
Neoadjuvant and adjuvant pembrolizumab plus standard of care (SOC) in resectable locally advanced head and neck squamous cell carcinoma (LA HNSCC): Exploratory efficacy analyses of the phase 3 KEYNOTE ...
Esophageal squamous cell carcinoma (ESCC) is the predominant histological subtype of esophageal cancer, accounting for ...
Pending the European Commission decision, Zynyz ® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results